These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 32005442)

  • 1. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
    Shinjyo N; Parkinson J; Bell J; Katsuno T; Bligh A
    J Integr Med; 2020 Mar; 18(2):125-151. PubMed ID: 32005442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Berberine in the Multi-Target Treatment of Senile Dementia.
    Huang M; Chen S; Liang Y; Guo Y
    Curr Top Med Chem; 2016; 16(8):867-73. PubMed ID: 26311424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular risk factors, cognitive decline, and dementia.
    Duron E; Hanon O
    Vasc Health Risk Manag; 2008; 4(2):363-81. PubMed ID: 18561512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine suppresses the ectopic expression of miR-133a in endothelial cells to improve vascular dementia in diabetic rats.
    Yin S; Bai W; Li P; Jian X; Shan T; Tang Z; Jing X; Ping S; Li Q; Miao Z; Wang S; Ou W; Fei J; Guo T
    Clin Exp Hypertens; 2019; 41(8):708-716. PubMed ID: 30472896
    [No Abstract]   [Full Text] [Related]  

  • 5. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
    Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
    Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
    Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of berberine in animal models of Alzheimer's disease: a systematic review of pre-clinical studies.
    Yuan NN; Cai CZ; Wu MY; Su HX; Li M; Lu JH
    BMC Complement Altern Med; 2019 May; 19(1):109. PubMed ID: 31122236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer's disease.
    Singh AK; Singh SK; Nandi MK; Mishra G; Maurya A; Rai A; Rai GK; Awasthi R; Sharma B; Kulkarni GT
    Cent Nerv Syst Agents Med Chem; 2019; 19(3):154-170. PubMed ID: 31429696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease.
    Jash K; Gondaliya P; Kirave P; Kulkarni B; Sunkaria A; Kalia K
    Drug Dev Res; 2020 Apr; 81(2):144-164. PubMed ID: 31820484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Syndrome as a Risk Factor for Alzheimer's Disease: Is Aβ a Crucial Factor in Both Pathologies?
    Campos-Peña V; Toral-Rios D; Becerril-Pérez F; Sánchez-Torres C; Delgado-Namorado Y; Torres-Ossorio E; Franco-Bocanegra D; Carvajal K
    Antioxid Redox Signal; 2017 Apr; 26(10):542-560. PubMed ID: 27368351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular cognitive impairment in diabetes mellitus: are prevention and treatment effective?
    Zavoreo I; Madžar Z; Demarin V; Kes VB
    Acta Clin Croat; 2014 Sep; 53(3):326-33. PubMed ID: 25509243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review.
    Shah K; Qureshi SU; Johnson M; Parikh N; Schulz PE; Kunik ME
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):250-61. PubMed ID: 19948301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine and barberry (Berberis vulgaris): A clinical review.
    Imenshahidi M; Hosseinzadeh H
    Phytother Res; 2019 Mar; 33(3):504-523. PubMed ID: 30637820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine: Pathways to protect neurons.
    Lin X; Zhang N
    Phytother Res; 2018 Aug; 32(8):1501-1510. PubMed ID: 29732634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional effects of berberine in modulating mitochondrial dysfunction and inflammatory response in the respective amyloidogenic cells and activated microglial cells - In vitro models simulating Alzheimer's disease pathology.
    Wong LR; Tan EA; Lim MEJ; Shen W; Lian XL; Wang Y; Chen L; Ho PC
    Life Sci; 2021 Oct; 282():119824. PubMed ID: 34265361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antidementia drugs].
    Müller-Spahn F; Sollberger D; Wollmer MA
    Ther Umsch; 2009 Jun; 66(6):432-40. PubMed ID: 19496039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged.
    Craft S
    Arch Neurol; 2009 Mar; 66(3):300-5. PubMed ID: 19273747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome, mild cognitive impairment, and dementia.
    Panza F; Frisardi V; Seripa D; Imbimbo BP; Sancarlo D; D'Onofrio G; Addante F; Paris F; Pilotto A; Solfrizzi V
    Curr Alzheimer Res; 2011 Aug; 8(5):492-509. PubMed ID: 21605050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HRT and dementia.
    Skoog I; Gustafson D
    J Epidemiol Biostat; 1999; 4(3):227-51; discussion 252. PubMed ID: 10695961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating gut microbiota as an anti-diabetic mechanism of berberine.
    Han J; Lin H; Huang W
    Med Sci Monit; 2011 Jul; 17(7):RA164-7. PubMed ID: 21709646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.